Pancreas Cyst Clinical Trial
Official title:
Histological Diagnostic Value of the Moray Micro Forceps in the Management of Pancreatic Cysts.
The prevalence of pancreatic cysts in the general population is high close to 1%. The diagnosis is most of the time fortuitous thanks to the improvement of the imaging resources available. These lesions include a large number of entities, some of with malignant potential. Mucinous lesions present a high risk of tumor transformation, justifying surgery, which is sometimes heavy. It appears essential to select the best patients to benefit from this type of treatment. For this purpose, the accuracy of the diagnostic means must be optimal. The Fine Needle Aspiration under Endoscopic ultrasound, validated in this context, have a low complication rate. It allows a cytological evaluation and analysis of tumor markers measurements in cystic fluid. However, cytopathological evaluation is only contributing in 1/3 to half of cases. The assays of markers (including the main one ACE) have high specificities but high insufficient sensitivities (less than 50%). Molecular techniques (K-RAS mutation in particular), of variable availability, allow to increase the sensitivity in association with the other diagnostic parameters. But the rate of false negatives remains above 20% to date. A diagnostic means to obtain a histology of the cyst wall would reduce considerably the risk of error. The Moray™ micro forceps is forceps that aims to provide a tissue sample of the wall of the pancreatic cyst. It is inserted into a commonly used 19 Gauge needle during the puncture of the cyst under endoscopic ultrasound. It could increase the accuracy diagnosis of the procedure. These forceps has recently become available to the practitioner and has obtained the CE marking. To date, no quality multi-center prospective evaluation has determined the capacity of to obtain a histology of the pancreatic cystic walls by this technique. Its safety must be also be accurately assessed.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04970056 -
Pancreatic Cancer Early Detection Consortium
|
||
| Recruiting |
NCT05155878 -
Prognostic Factors in Periampullary Tumors and Cysts
|
||
| Recruiting |
NCT03536793 -
Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
|
||
| Completed |
NCT03731819 -
Establishment of Abbreviated Pancreatobiliary MRI Protocol
|
N/A | |
| Completed |
NCT06227871 -
A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes
|
||
| Recruiting |
NCT03855800 -
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
|
N/A | |
| Recruiting |
NCT05714111 -
Radiology Registry on Pancreatic Malignancies
|
||
| Recruiting |
NCT04104230 -
Quebec Pancreas Cancer Study
|
||
| Recruiting |
NCT03568630 -
Blood Markers of Early Pancreas Cancer
|
||
| Active, not recruiting |
NCT03305146 -
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
|
N/A | |
| Completed |
NCT03820531 -
DNA-mutation Analysis in Cyst Fluid of Suspected Intraductal Papillary Mucinous Neoplasia of the Pancreas
|
N/A | |
| Recruiting |
NCT06055010 -
Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
|
||
| Recruiting |
NCT04324294 -
Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions
|
Phase 1 | |
| Completed |
NCT03172572 -
A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers
|
||
| Completed |
NCT01807325 -
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
|
||
| Completed |
NCT04064034 -
ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer
|
N/A |